Background

Cord Blood America (CBAI.OB) is a company devoted to the research and development of uses for stem cells as well as storage for the cells themselves. As several other companies in the same sector accomplish, Cord Blood America provides a service to parents. This process involves the safe, painless harvesting of stem cells through the umbilical cord at birth. Theses stem cells can then be used as an, "insurance policy" if you will, against certain medical issues such as brain damage, brain degeneration and different forms of cancer such as Leukemia and cancerous tumors. There is much more potential for treatment that is currently being researched as well such as treatments for baldness, Parkinson's and Alzheimer's.

What sets Cord Blood America apart from the rest?

There are several companies that provide the same services that Cord Blood America provide. However, Cord Blood America does execute certain things especially well that set them apart from the company by a considerably large margin.

First of all, if you have had experience with this process at all you may be aware of the many factors in facilitating a successful extraction and preservation of stem cells. Stem cells are temperature and time sensitive materials that must be handled appropriately. Cord Blood America ensures that this happens by working closely with there partners providing safe and reliable transportation of the stem cells to the proper facilities. After the stem cells are preserved Cord Blood provides ideal conditions and 24 hour support to its clients.

Secondly, Cord Blood America is the leading stem cell company fighting for stem cell extraction from umbilical cord blood to become a standardized medical procedure packaged with the standard birthing process with health insurance companies. So far the company has been successful in this with smaller health care providers as well as Blue Cross in certain areas. This, mainstreaming if you will, of the cord blood process would vastly improve public awareness of this procedure as well as increase the widespread use of this method as treatment in curable ailments significantly increasing revenue in that department.

Lastly, Cord Blood America is a sound company evidenced by many of there financial decisions. to include a few would be their acquiring of smaller companies and using the liquidity from those companies to fund its state of the art 17,000 sq. ft. lab in Las Vegas, Nevada. Once completed and ready to store stem cells this January, this facility will be the largest of its kind in the United States. And yet another reason why Cord Blood America is a sound company, their elimination of debt. Cord Blood America managed to reduce there debt by $8.9 million, $3.7 of which was in the third quarter. I believe that their current financial strategy outlined in their latest press release (Fri. Oct. 23) is a smart move that will ultimately drive the company closer to their goal of being the worlds most respected stem cell preservation company.

What all this information adds up to

Cord Blood America offers an unprecedented amount of worth to the table as a competitor in the stem cell preservation industry. They accomplish this through unrivaled process, ambitious goals of the standardization of the cord blood process, as well as through key financial decisions that ultimately propel Cord Blood America further ahead from the competition making it a wise investment decision.

Disclaimer: I DO NOT hold CBAI. Do not base any investment decisions upon materials on this page.